MASKING CD94/NKG2A USING A NOVEL THERAPEUTIC MAB RESULTS IN SIGNIFICANT SUPPRESSION OF IL-6 LEVELS AND REDUCED OSTEOCLAST FORMATION IN RHEUMATOID ARTHRITIS EX VIVO CULTURES by Soderstrom, K, Sundstrom, Y, Berg, L, Schepis, D, Galsgaard, E, Klareskog, L, Wagtmann, N

BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-ME... by Nielsen, N, Galsgaard, E, Ahern, D, Andersen, M, Spee, P, Feldmann, M, Brennan, F, Soederstroem, K

Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses. by Germain, C, Meier, A, Jensen, T, Knapnougel, P, Poupon, G, Lazzari, A, Neisig, A, Håkansson, K, Dong, T, Wagtmann, N, Galsgaard, E, Spee, P, Braud, V

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblas... by Nielsen, N, Pascal, V, Fasth, A, Sundström, Y, Galsgaard, E, Ahern, D, Andersen, M, Baslund, B, Bartels, E, Bliddal, H, Feldmann, M, Malmström, V, Berg, L, Spee, P, Söderström, K